HomeMAYNF • OTCMKTS
add
Mayne Pharma Group Ltd
Previous close
$2.61
Year range
$2.42 - $4.59
Market cap
359.92M AUD
Avg Volume
639.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 100.24M | — |
Operating expense | 59.80M | — |
Net income | -51.84M | — |
Net profit margin | -51.72 | — |
Earnings per share | — | — |
EBITDA | 11.68M | — |
Effective tax rate | 14.89% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.28M | -32.19% |
Total assets | 1.14B | -8.35% |
Total liabilities | 688.99M | 12.40% |
Total equity | 454.19M | — |
Shares outstanding | 81.25M | — |
Price to book | 0.47 | — |
Return on assets | -0.72% | — |
Return on capital | -1.67% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -51.84M | — |
Cash from operations | 6.71M | — |
Cash from investing | -6.88M | — |
Cash from financing | 175.50K | — |
Net change in cash | 420.50K | — |
Free cash flow | 12.74M | — |
About
Founded
2005
Website
Employees
900
